INTEGRATED BIOPHARMA INC·4

May 29, 3:36 PM ET

Masi Dina 4

4 · INTEGRATED BIOPHARMA INC · Filed May 29, 2019

Insider Transaction Report

Form 4
Period: 2019-05-24
Masi Dina
Chief Financial Officer
Transactions
  • Award

    Stock Option (right to buy)

    2019-05-24+150,000150,000 total
    Exercise: $0.21Exp: 2029-05-24Common Stock (150,000 underlying)
Footnotes (1)
  • [F1]The option vests 50% (75,000) on grant date (May 24, 2019) and in three equal annual installments for the remaining 50% (75,000) beginning on May 24, 2020.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT